SEC Company Response from PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081) (PTCT) — Jun 17, 2013
PTC THERAPEUTICS, INC. (PTCT) (CIK 0001070081)
Date: June 17, 2013 · CIK: 0001070081 · Accession: 0001104659-13-049658
AI Filing Summary & Sentiment
File numbers found in text: 333-188657
Letter
Re: PTC Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-188657 Request for Acceleration
PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD, NEW JERSEY 07080
June 17, 2013
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, PTC Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-188657), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on June 19, 2013, or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
(a) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(b) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(c) the Registrant may not assert staff comments and the declaration of effectiveness of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
[The remainder of this page is intentionally left blank.]
Very truly yours,
PTC Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD, NEW JERSEY 07080 June 17, 2013 Via EDGAR Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Re: PTC Therapeutics, Inc. Registration Statement on Form S-1 File No. 333-188657 Request for Acceleration Ladies and Gentlemen: Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, PTC Therapeutics, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-1 (File No. 333-188657), as amended (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on June 19, 2013, or as soon thereafter as practicable. The Registrant hereby acknowledges that: (a) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement; (b) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and (c) the Registrant may not assert staff comments and the declaration of effectiveness of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States. [The remainder of this page is intentionally left blank.] Very truly yours, PTC Therapeutics, Inc. By: /s/ Mark E. Boulding Name: Mark E. Boulding Title: Executive Vice President and Chief Legal Officer